Search results
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 10 hours agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Novavax NVAX , and it's something market players shouldn't ignore. Our tracking of public ...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 1 day agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax has a 1 year low of $3.53 and ...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 17 hours agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoNovavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 3 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 7 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...